
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Usherin CRISPR/Cas9 KO Plasmid (m) | sc-423630 | 20 µg | $397.00 |
Ush2a encodes usherin, a large extracellular matrix–associated transmembrane protein enriched at the periciliary membrane complex of sensory epithelia, where it supports mechanosensory structure and long-term cellular integrity. In mouse, usherin contributes to stereocilia organization and photoreceptor maintenance by coordinating protein complexes involved in cell adhesion, ciliary trafficking, and cytoskeletal coupling. Disruption of USH2A is strongly associated with Usher syndrome type II and retinitis pigmentosa, linking this gene to pathways governing cilium-dependent signaling and sensory neuron homeostasis. Accordingly, Ush2a loss-of-function models are used to interrogate ciliary transport, extracellular scaffold assembly, and degeneration-related stress responses in retina and inner ear contexts.
Usherin CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Ush2a gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Ush2a together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Ush2a open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Usherin protein expression.
This CRISPR knockout system enables efficient generation of Ush2a-deficient cell models for investigation of Usherin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.